Syndrome News and Research

RSS

Ticagrelor therapy, without aspirin, can benefit patients with acute coronary syndrome

Patients with acute coronary syndrome (ACS) who stopped taking aspirin three months after the insertion of a coronary stent and then took the anti-platelet medication ticagrelor alone for nine months had fewer episodes of bleeding and no increase in heart attacks, stroke or other adverse events caused by blockages in the arteries, compared with patients who took both aspirin and ticagrelor for a year.

31 Mar 2020

How to boost your immune system to fight coronavirus

As the world struggles with the coronavirus pandemic, more and more people are trying to protect themselves against the virus by all means possible. There are currently no vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), so boosting the immune system by way of diet, regular exercise, and sleep are sensible measures.

31 Mar 2020

United States tracking mobile phones to map spread of COVID-19

United States officials are using location data from mobile phone users to track the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is causing the global pandemic of COVID-19. The USA, as of today, has a total of 163,807 cases of COVID-19 and has recorded 3,008 deaths.

30 Mar 2020

Origins of SARS-CoV-2 – natural or man-made?

With over 780,000 individuals across the world infected and over 37,000 dead, the world is gripped by the pandemic caused by the novel strain of coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

30 Mar 2020

TWILIGHT trial: Brilinta reduces bleeding compared to dual therapy in high-risk coronary patients

Results from two subgroup analyses of the Phase IV independent TWILIGHT trial funded by AstraZeneca showed Brilinta (ticagrelor) monotherapy reduced the risk of clinically relevant bleeding over 12 months compared to aspirin plus Brilinta in high-risk coronary patients.

From AstraZeneca 30 Mar 2020

COVID-19: What is social distancing?

The coronavirus disease (COVID-19) is a contagious disease caused by a novel coronavirus, akin to previous infections such as severe acute respiratory syndrome (SARS) in 2002 and the Middle East Respiratory Syndrome coronavirus disease (MERS-CoV) in 2012.

30 Mar 2020

Coronavirus shown to spread in high heat and humidity

A new study explores the possibility that the novel coronavirus, which is ravaging the world, can spread in hot and humid conditions, dispelling the view held by some investigators that the virus is more easily transmissible in colder climates.

30 Mar 2020

Unraveling gut-to-brain communication paves way for targeted treatments

Scientists at Flinders University have, for the first time, identified a specific type of sensory nerve ending in the gut and how these may 'talk' to the spinal cord, communicating pain or discomfort to the brain.

30 Mar 2020

Taking ticagrelor alone better for patients with complex heart disease

Patients with complex heart disease who stopped taking aspirin three months after the insertion of one or more coronary stents and then took the anti-platelet medication ticagrelor alone for a year had fewer episodes of bleeding and no increase in heart attacks, stroke or other adverse events caused by blockages in the arteries, compared with patients who took both aspirin and ticagrelor over the same period.

30 Mar 2020

AI tool could accurately predict which COVID-19 patients will develop respiratory disease

An artificial intelligence tool accurately predicted which patients newly infected with the COVID-19 virus would go on to develop severe respiratory disease, a new study found.

30 Mar 2020

Engineers innovate soft, flexible brain implant

A team have established a soft, flexible neural implant that can mold to the brain’s contours without damaging the tissue.

30 Mar 2020

COVID-19 and its effects on the cardiovascular system

Researcher have reviewed the evidence showing the effects of the SARS-CoV-2 or novel coronavirus infection (COVID-19) on the cardiovascular system. Their study titled, “Potential Effects of Coronaviruses on the Cardiovascular System: A Review,” was published in the latest issue of JAMA Cardiology.

29 Mar 2020

Genetic mutation found to improve cognitive flexibility in mice

Researchers at the National Institutes of Health have discovered in mice what they believe is the first known genetic mutation to improve cognitive flexibility--the ability to adapt to changing situations.

27 Mar 2020

Protect the lives of healthcare workers fighting against disease outbreaks

Protect healthcare workers from dying from disease outbreaks while in the line of duty, urges Ifeanyi M. Nsofor. The continuing Coronavirus (COVID-19) outbreak is a reminder that healthcare workers are in the line of fire when responding to infectious disease outbreaks and we must ensure that they are protected.

27 Mar 2020

UC Davis launches two clinical trials to evaluate treatments for COVID-19

UC Davis Health has two clinical trials underway for hospitalized patients with severe COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2.

27 Mar 2020

Brain mapping shows motor regions for the hand may be connected to entire body

Neuroscientists have published findings which reveal that the motor region for the hand connects to the entire body.

27 Mar 2020

Outcomes of mothers giving birth during COVID-19 pandemic

Researchers from Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China have looked at the outcomes of pregnant mothers with COVID-19 and their newborns. Their study titled, “Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-center, descriptive study” was published in the latest issue of the journal The Lancet, Infectious Diseases.

26 Mar 2020

FDA approves immune-modulating therapy for treatment of multiple sclerosis

The U.S. Food and Drug Administration has approved ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis.

26 Mar 2020

What happens when COVID-19 and cardiovascular diseases mix?

The world has been brought to a stand-still by the COVID-19 pandemic that has affected 197 countries, areas and territories, infected 467,594, and killed 21,181 individuals as of today. COVID-19 disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a single-stranded RNA virus, contagious in humans.

25 Mar 2020

Transmission of COVID-19 among cancer patients in China

Researchers from Zhongnan Hospital of Wuhan University in China in collaboration with those from the National Cancer Centre Singapore, have come up with a study that reveals the transmission of the SARS-CoV-2 or novel coronavirus among patients with cancer in China.

25 Mar 2020